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The health care reform movement in the USA and increased
requirements by regulatory agencies continue to have a major impact
on the pharmaceutical industry and the laboratory. Laboratory
management is expected to improve effciency by providing more
analytical results at a lower cost, increasing customer service,
reducing cycle time, while ensuring accurate results and more
effective use of their staff. To achieve these expectations, many
laboratories are using robotics and automated work stations.
Establishing automated systems presents many challenges for
laboratory management, including project and hardware selection,
budget justification, implementation, validation, training, and
support. To address these management challenges, the rationale
for project selection and implementation, the obstacles encountered,
project outcome, and learning pointsfor several automated systems
recently implemented in the Quality Control Laboratories at Eli
Lilly are presented.
Introduction
The health care reform movement and increased regulatory
requirements continue to have a major impact on the
pharmaceutical industry. Changing customer bases,
combined with more emphasis on lowering costs and a
demand tbr more accurate data are greatly affecting
the way the industry does business, both internally
and externally. The pharmaceutical industry is being
fbrced to become more efficient and cost effective to
remain competitive in this changing market. As a result,
laboratory management is expected to improve efficiency
by providing more analytical results at a lower cost,
increasing customer service, reducing cycle time, while
ensuring accurate results and more effective use of their
staff. To achieve these expectations, many laboratories
are using robotics and automated work stations. Auto-
mation has been utilized to improve efficiency and
productivity, reduce cycle times, improve technical staff
utilization, provide a safer work environment, and
improve the quality of analytical results. However,
establishing automated systems in the laboratory present
many challenges for laboratory management, including
project and hardware selection, budget justification,
implementation, validation, training, and support.
Project and hardware selection
Project selection is the first major challenge for laboratory
management, and, in many cases, can be a key factor in
whether a project fails or succeeds. It can also have an
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impact on the establishment of an automation program
and future ofautomation projects in an area. Automation
has typically been utilized to improve efficiency and
productivity, better utilize technical staff, provide a safer
work environment, and improve the quality of analytical
results. The first task is to identify potential opportunities
for automation. This can be accomplished in several ways.
One approach is to identify available technology and
identify applications that may be able to utilize this
technology. This can be quite successful for work stations
when just starting to establish automation in a laboratory.
However, this may not address specialized needs or
applications where the benefits of automation may be
greater. The opposite approach is to identify tasks or
assays that can benefit from automation and then identify
technology that can address these needs. This approach
usually is more amenable to custom automation projects
and results in better project selection and utilization of
technology.
One of the best ways we have found to identify oppor-
tunities is to combine these two approaches using a
cross-functional team oftechnical and automation experts
from such areas as the laboratories, systems, engineering,
development, and management. Discussions are held with
laboratory analysts to identify those assays and/or tasks
that are labour intensive, time consuming, high volume,
repetitive, highly variable, result in unstable inter-
mediates, or utilize compounds, solvents, reagents or
techniques that present a health or safety risk. Other
factors that should also be discussed are work flow through
the laboratory, assay turn-around needs, laboratory
space constraints, technical level of the staff and support
groups, and openness to new technology. This approach
has been used several times to date, both in Indianapolis
and in at least one affiliate, and has helped identify
numerous automation and/or productivity improvement
opportunities.
Once potential opportunities are identified, final selection
of a project or projects is the next critical step. Business
needs and drivers most often will impact the final decision.
In the pharmaceutical industry, improving efficiency,
lowering costs, increasing customer service, reducing cycle
time, and effective use of staffs are key drivers when
assessing benefits of undertaking a project. Other business
drivers to consider are the availability of the necessary
resources to implement projects, availability of project
capital, and time constraints, which impact the ability to
implement a project. Almost always, the decision will
hinge on the benefits observed versus the cost or ease of
implementing the project. Evaluating the benefits versus
the ease ofimplementation can be accomplished in several
ways, and each company has its process for making this
decision. One tool that is beneficial is an opportunity map,
shown in figure 1.
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Figure 1. Opportunity map for project selection.
This tool was first used as part of a quality/performance
improvement program implemented at Lilly in the late
1980s known as ’Performance Excellence. To develop the
opportunity map, each project was evaluated solely on
its benefits, assigning a value zero to five, with five being
high benefit and zero being low benefit. Similarly, each
project was evaluated solely on its ease ofimplementation,
again assigning a value of zero to five, with five being
easily implemented and zero being difficult to implement.
For example, in figure 1, project A, would have a benefit
value offbur (high benefit) and an ease ofimplementation
value of four (easily implemented). This project might
correlate to an application using readily available
technology, requiring minimal training of analysts, can
be started up with minimal effort, and will reduce cycle
time, headcount, etc. in the laboratory. Those projects in
the upper right quadrant would be projects easily
implemented that would provide the most benefit.
The projects would be rank ordered, based on the diagonal
as you move from upper right to lower left. In the example,
this would be Projects A, B, C, D, E, F. This evaluation
of benefits and ease of implementation can be very data
driven based on a thorough evaluation of technology,
staffing etc., or based more on available data and
knowledge of the project scope. The latter approach
typically is used when a large number of opportunities
have been identified and the objective is to effectively
reduce the list to a manageable number of projects prior
to doing an in depth evaluation of each project.
Hardware evaluation and/or selection can be incor-
porated into the project selection process at various places.
Some knowledge ofavailable hardware, hardware vendors,
and the services they can provide is important throughout
the selection process, especially when assessing the ease of
implementation. Hardware selection can be affected by
several factors. The first to consider is available space for
automated equipment--limited space for laboratories is
becoming more and more of an issue for laboratory
management. Bench top workstations, such as the Zymark
Benchmate or Benchmate Tablet Processing Workstation
(TPW) (Zymark Corporation, Hopkinton, MA), require
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minimal space and/or laboratory modifications. However,
the trade off is usually limited programming flexibility
and customization capabilities. Full size robotics options,
such as the Zymate (Zymark Corporation, Hopkinton,
MA) or Mitsubishi Micro Robot (Mitsubishi Electronics
Corp., Japan) can require significantly more space and
typically require laboratory modifications, but can be fully
customized and provide greater flexibility.
A second factor is the availability and capability of the
hardware itself. Usually several vendors can provide
hardware to meet customers’ needs, some better than
others. For example, some vendors can supply not only
the robotics arm, but also complete systems and/or many
of the integrated components, such as power and event
controllers, centrifuges, liquid handling, racks etc. One
very important aspect of hardware selection is to choose
the hardware that is best suited for the task. Physical
specifications can influence this decision. For example, the
load capacity of the robotics arm was a factor in hardware
selection for a feed assay application (Hinshaw et al. [1])
in our laboratory due to large sample volume and
container requirements. Programming and system flexi-
bility can also impact the selection ofhardware, depending
on the application. Many times this is true for work-
stations, which tend to be less flexible, limiting their
suitability for more specialized applications. Workstations
typically do, however, offer the flexibility of being used
for multiple assays or tasks very easilymthis is not always
possible for larger robotic.s systems which tend to be more
dedicated to a specific task or methodology. Flexibility
can be built into these systems, but it usually increases
the complexity of the programming and the system.
The complexity of the project can be also affected by the
selection of hardware. This is another factor that needs
to be considered. Some vendors’ hardware is better suited
for certain applications than others due to ease of
programming, availability of integrated components,
design, etc. For example, using the Mitsubishi Micro
Robot for automated dissolution testing is feasible, but
the complexity of this system would be greatly increased.
A Zymate-based automated dissolution system would
result in a less complex system due to the availability
of the components from Zymark and their previous
experience with this application.
The vendor is also a factor when selecting hardware. More
and more vendors are getting involved in laboratory
automation, workstations, and systems integration, making
hardware selection even more difficult. Each vendor offers
a wide variety of hardware, services, and support which
can differentiate them from one another, as well as
be very beneficial to the laboratory manager. Systems
integration, custom systems and components, and valida-
tion services are a few examples of services that can make
a difference in hardware selection when multiple options
exist. The vendor also has a big influence on another
hardware selection factor--cost. In the pharamaceutical
industry, more and more emphasis is being placed on
reducing manufacturing costs. As a result, laboratory
management is expected to improve laboratory produc-
tivity and efficiency by providing more analytical results
at a lower cost with less staff. The cost versus benefits
gained of automated systems and hardware can mostM. L. Rutherford ISLAR 1994
often be the biggest factor for resourcing and funding
a project.
The last factors in hardware selection are expertise and
support. External expertise and support from the vendor
is important, but to be truly efficient and effective, it is
even more important to have these skills internally.
Standardization on a few types of hardware is beneficial
since it allows for the development of internal expertise
and the necessary support functions. However, it is
important not to let this be the primary factor in selecting
hardware, especially when better options exist.
Budget justification
Once a project has been selected and the hardware options
evaluated, the next major challenge is the budget
justication. Automated systems can be justified in many
ways. One of the more common ways is through efficiency
and productivity gains. These gains can be based on
increased sample capacity, absorption of additional
workload, more efficient processing of samples, increased
utilization of equipment etc. Based on the cost savings for
each of these gains, one .should be able to estimate the
Return on Investment, or ROI, for the proposed system.
This is another way of justifying the purchase on an
automated system. Typically, an ROI of two years or less
is considered good, but varies from company to company.
For example, purchase of one of our Benchmate TPW’s
was based on the ability to increase our sample capacity
for several assays. When the ROI was estimated, it showed
that the system would pay for itself in six to nine months
based purely on the analysts hours saved. It also allowed
us to absorb some additional assay work that otherwise
would not have been possible without adding resources.
Larger robotics systems typically take longer to recoup
the costs.
Another less common way to justify automated systems
is through improved safety, including waste reduction/
elimination, reduced exposure to potentially hazardous
compounds, solvents, and reagents. The reduction in
waste generated is a key aspect to evaluate, especially as
the cost ofdisposal ofsolvents and chemicals gets more and
more expensive. This opportunity is primarily the result
ofthe reduced volumes used during preparation ofsamples
on an automated system. Exposure to solvents and
chemical compounds is also becoming more of a concern.
More and more new drug entities are highly potent, and
prolonged exposure can be harmful. For example, using
the homogenizer on the Benchmate TPW to grind tablets
in solution greatly is significantly safer than utilizing a
mortar and pestle to break up the tablet and then
dissolving in solution.
Another opportunity tbr justifying the purchase of an
automated system is better staffutilization. By automating
routine and repetitive tasks, analysts are freed up
to do more complex and challenging tasks, rather than
eliminating their job. Staff utilization and headcount
savings was used to help justify several systems in our
laboratories during the last few years. Saving of one to
two Full-Time Equivalent (FTEs) have been demonstrated
by utilizing a Benchmate TPW for content uniformity
testing of several projects. Similarly, estimated savings for
implementing an automated dissolution system is two to
four FTEs.
Automated systems can also be justified on the grounds
of better quality data and results. One distinct advantage
of automated systems is that processes are performed very
uniformly. With this can come improved assay precision
and performance. This is especially true when prepared
samples are unstable or degrade upon sitting in an
autosampler. In one case, a 50 improvement in method
variability was realized by transferring the manual
analytical method to a Benchmate TPW. In addition to
the reduction in method variability, better customer
service and reduced cycle time was obtained. Both of these
factors can also be used as budget justifications. Reducing
laboratory cycle times can have an impact on in-process
inventories, provide more timely information to make
better process adjustments, etc. Cycle time reductions,
which utilimately improves customer service, have been
greatly impacted by the use of automation in our labs.
Some assays which required several analysts multiple days
to perform are now completed in less than one day and
require only a single analyst to support the automated
system.
Implementation
The next major challenge for laboratory management is
implementation. Just like the project and hardware
selection, there are several factors to consider that can
impact an implementation plan. The first consideration
is resource availability to carry out the implementation.
The first question to ask is ’does the necessary expertise
and resources exist in-house that can carry out the
development, programming, and installation of the
automated system or must it be contracted to the vendor
or a systems integrator?’ The level of expertise required
does increase with the complexity of the application. For
that reason, it is very important for laboratory manage-
ment to consider the complexity of the project when
developing an implementation strategy. Simpler applica-
tions, such as a Benchmate or Benchmate TPW, can
usually be implemented in-house with minimal difficulty.
However, when it comes to more complex automation
such as a robotics system, there are drawbacks to both
in-house implementation and contracting it out. A big
drawback ofin-house development is having the expertise
and skills necessary to implement a complex system. Many
laboratories, especially those just getting involved with
automated systems, will not have the necessary level of
expertise, making contracting a more viable option. The
big drawback with contracting is less control and
understanding of how the system is programmed and
components are integrated. As a result, one becomes very
dependent on the contractor for troubleshooting problems
and making modifications. Such is the case with a new
Zymate automated dissolution system being installed in our
laboratories. Due to a lack of resources with the necessary
expertise and the complexity of the system, as well as an
aggressive time line, the only option was to purchase a
complete dissolution robotics system from Zymark.
A third consideration that can affect implementation
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is the time ’line’ for completion. Often time lines
are very aggressive and as a result do slip to varying
degrees. One reason they typically slip is under estimation
of the time necessary to come up the learning curve
on a new automated system. Coming up the learning
curve can range from a few weeks to more than a year
and is very dependent again on the complexity of
the system.
Validation
Validation is the next critical step in implementing
a successful automated system and represents probably
one of the ’newest’ challenges for laboratory manage-
ment. Over the last few years, the importance of
equipment and system validation throughout the labora-
tory has been increasing due to stricter interpretations
ofGMP guide lines. The increased interest in validation
by scientists, vendors, and regulatory agencies reinforces
this importance. There are many different approaches
to validating automated systems as demonstrated by
the numerous papers presented at various conferences
during the last three to four years. In general, though,
validation can be paired down to a few key aspects.
They include installation and operational qualification
of critical components, demonstrating acceptable per-
formance characteristics of the system as a whole, as
well as developing a strategy to monitor and ensure
acceptable performance characteristics of the automated
system. This translates into a significant increase in
documentation. Consequently, the process of validation
can be very time consuming. In the past, validation was
very important to ensuring proper implementation of an
automated system. Today, with more emphasis being
placed on the quality and accuracy of analytical results,
validation has become an absolute requirement to
guarantee product quality.
Training and support
The last management challenge is training and support,
which is essential to ensuring the success of an automated
system and an automation program. Technical training
is very important to this success. Many vendors offer
training classes for their hardware and systems, but that’s
just one aspect of technical training. Having the right
people with the right background and basic skills first is
just as important. For example, we have found that
electronic and instrumentation skills are, at times, more
important than analytical skills for analysts developing,
implementing, and supporting automated laboratory
systems. As a result, many of our analysts that support
our automated systems have two-year electrical engineering
technology degrees, and in many cases have developed
into some of our top analytical laboratory analysts, but
not without a significant investment in technical training.
The same can be said for our instrument repair technicians.
We are very fortunate to have in-house instrument
maintenance and repair services for many ofour analytical
instruments and automated systems. This greatly reduces
down time due to component failures since they can
respond immediately.
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Support functions are also very important to the success
of an automated system and an automation program. As
mentioned previously, vendor support is very important,
especially when starting to establish automation in an
area. It’s probably no surprise that the quality of
the support is typically dependent on the quality
of the individuals that you interact with. Developing
good working relationships with vendors and their
representatives is also important, as is their understanding
of your direction, goals, and needs so as to better serve
you, their customer.
Management support is also very important. Laboratory
management, through his or her support, can ensure the
success or failure ofan automated system and/or program.
Laboratory management must provide support to those
directly involved with automated systems. This support
must come in the form of training, resources, and funds
to adequately develop, implement, validate, and support
automated systems and the program. Laboratory manage-
ment can also serve as a ’champion’ for laboratory
automation, by educating upper management and other
areas on the benefits and limitations of laboratory
automation, as well as helping them understand the
direction the technology is going to ensure future success.
In addition, it is important to keep up with current
technology and incorporate this into the future direction
of his or her area of influence. The ’champion’ should
also be coach, developing other ’champions’, because a
true measure of the success of a ’champion’ is the
continued automation success of an area long after he or
she has moved on.
Conclusions
Laboratory management will continue to be faced with
new and different challenges as business focuses and
customers change. Expectations to improve laboratory
efficiency and productivity, reduce cycle times, improve
technical staff utilization, provide a safer work environ-
ment, and improve the quality of analytical results will
continue to drive the need for laboratory automation.
Laboratory management must look for new opportunities
to utilize automation as well as serve as a ’champion’
of this technology in order to meet these exceptions.
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